News tagged with biomed central

Related topics: breast cancer , protein

Commuting - bad for your health?

A mobile workforce can help improve a country's economy but the effects of commuting on the health of commuters and on the costs to industry in terms of sick days is largely unknown. From a commuter's point of view, the advantages ...

Oct 31, 2011
popularity 0 comments 3

Proteins used to map the aging process

Loss of muscle mass is not only associated with disease, such as HIV and cancer, but also with the normal aging process. Anabolic steroids are sometimes used to reverse loss of lean muscle tissue but they can have unwanted ...

Jun 19, 2011
popularity 0 comments 0

How music prevents heart transplant rejection

Music has a fundamental affect on humans. It can reduce stress, enhance relaxation, provide a distraction from pain, and improve the results of clinical therapy. New research published in BioMed Central's open access journal ...

Mar 22, 2012
popularity 0 comments 1

Stem cell therapy reverses diabetes

Type 1 diabetes is caused by the body's own immune system attacking its pancreatic islet beta cells and requires daily injections of insulin to regulate the patient's blood glucose levels. A new method described in BioMed ...

Jan 10, 2012
popularity 0 comments 1

Depressed? Crossed wires in the brain

Major depressive disorder (MDD) is a severely debilitating illness characterized by sadness and an inability to cope. Not only does it affect a person's ability to concentrate and make decisions, it also alters their ability ...

Dec 08, 2011
popularity 0 comments 0

BioMed Central

BioMed Central (BMC) is a UK-based for-profit scientific publisher specializing in open access publication. BMC publishes over 180 scientific journals, and describes itself as the first and largest open access science publisher. BMC sister companies publish the Chemistry Central and PhysMath Central journals. The Chairman is Vitek Tracz and the Publisher is Matt Cockerill.

Most titles are open access, including its flagship journals Journal of Biology, Molecular Cancer Malaria Journal, the innovative Journal of Negative Results in BioMedicine and the BMC journal series including the leading titles BMC Biology and BMC Medicine. Others are open access for the research articles portion only, such as Genome Biology, Arthritis Research & Therapy, Breast Cancer Research, andCritical Care. Some review titles, such as Current Opinion in Drug Discovery & Development are entirely subscription based. Open access content is released under the Creative Commons "Attribution" license which grants permission to reuse publications and produce derivative work.

In October 2008, it was announced that BMC, Chemistry Central, and PhysMath Central, had been acquired by Springer Science+Business Media. Previously, since its creation, the company was part of Science Navigation Group, chaired by Vitek Tracz, which also owns The Scientist (a popular science magazine—the daily news section is free access; the remainder is by subscription), Faculty of 1000 (a subscription-only current awareness service highlighting recent biological research), Global DataPoint, People's Archive and, in the past, two other companies which had previously been acquired by Springer, Images.MD (a medical image database) and Current Medicine.

In November 2008, BMC became an official supporting organisation of HIFA2015 (Healthcare Information For All by 2015).

This text uses material from Wikipedia licensed under CC BY-SA